Trial Profile
Effect of tocilizumab and its association with a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5) and IL-6 in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 16 Jun 2015 New trial record